Related references
Note: Only part of the references are listed.Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
Ganjun Yu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies
Sven Christian et al.
LEUKEMIA (2019)
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties
Liangxian Cao et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion
Sujatha Chilakala et al.
SCIENTIFIC REPORTS (2019)
An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS
Jun-ichiro Kida et al.
LEUKEMIA (2018)
Single-cell bioluminescence imaging of deep tissue in freely moving animals
Satoshi Iwano et al.
SCIENCE (2018)
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Marcus J. G. W. Ladds et al.
NATURE COMMUNICATIONS (2018)
Dihydroorotate dehydrogenase Inhibitors Target c-Myc and Arrest Melanoma, Myeloma and Lymphoma cells at S-phase
Mathura Subangari Dorasamy et al.
JOURNAL OF CANCER (2017)
Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia
David B. Sykes et al.
CELL (2016)
Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform
Liangxian Cao et al.
PLOS ONE (2016)
Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation
Marla Weetall et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2016)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Regulation of mammalian nucleotide metabolism and biosynthesis
Andrew N. Lane et al.
NUCLEIC ACIDS RESEARCH (2015)
MYC oncogene in myeloid neoplasias
M. Dolores Delgado et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Establishment of a Human Allergy Model Using Human IL-3/GM-CSF-Transgenic NOG Mice
Ryoji Ito et al.
JOURNAL OF IMMUNOLOGY (2013)
Development of an All-in-One Inducible Lentiviral Vector for Gene Specific Analysis of Reprogramming
Tomoyuki Yamaguchi et al.
PLOS ONE (2012)
Vidofludimus Inhibits Colonic Interleukin-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action
Leo R. Fitzpatrick et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis
A. Matsuoka et al.
LEUKEMIA (2010)
A distinct expression of various gene subsets in CD34+cells from patients with early and advanced myelodysplastic syndrome
Alzbeta Vasikova et al.
LEUKEMIA RESEARCH (2010)
Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype
Daniel T. Starczynowski et al.
NATURE MEDICINE (2010)
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
Paul W. Hollenbach et al.
PLOS ONE (2010)
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells
Philipp Baumann et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
Many are called MDS cell lines: One is chosen
Hans G. Drexler et al.
LEUKEMIA RESEARCH (2009)
Azacytidine causes complex DNA methylation responses in myeloid leukemia
Carlo Stresemann et al.
MOLECULAR CANCER THERAPEUTICS (2008)
CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins
Elaine M. Sloand et al.
BLOOD (2007)
A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination
Kazuyoshi Yanagihara et al.
CANCER RESEARCH (2006)
Share Paper
